Essais liés10clinical trials
VilleSan Diegolocalisation
PaysUnited Stateslocalisation
SourcelocaleCSV/MySQL

Informations

centre

Synchronisé depuis ClinicalTrials.gov — NCT07517263

Ouvrir le site du centre

Essais cliniques associés

10
MoléculeIndication / populationPhaseNCTTitreStatut
Inclisiran sodium 300 mg (equivalent to 284 mg inclisiran) in 1.5 mL Maladie coronarienne Phase 3 NCT05739383 A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients. ACTIVE_NOT_RECRUITING
Cryoneurolysis Cancer Non applicable NCT05444361 Ultrasound-Guided Percutaneous Cryoneurolysis to Treat Postoperative Pain After Mastectomy ENROLLING_BY_INVITATION
NRTX-1001 Épilepsie Phase 3 NCT05135091 Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (EPIC (EPIlepsy Cell Therapy)) RECRUITING
Vicadrostat Insuffisance cardiaque Phase 3 NCT06935370 A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart RECRUITING
Pelacarsen (TQJ230) Accident vasculaire cérébral Phase 3 NCT07517263 An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230) ACTIVE_NOT_RECRUITING
PIONEER — Prospective Natural History Study of POLG Disease Épilepsie À vérifier NCT07775872 PIONEER — Prospective Natural History Study of POLG Disease NOT_YET_RECRUITING
AOC 1020 Myopathies Phase 2 NCT06547216 FORTITUDE-OLE — Phase 2 Open-label Extension Study of AOC 1020 in Participants With Facioscapulohumeral Muscular Dystrophy (FSHD) ACTIVE_NOT_RECRUITING
AOC 1020 Myopathies Phase 1/2 NCT05747924 FORTITUDE — Phase 1/2 Study of AOC 1020 in Participants With Facioscapulohumeral Muscular Dystrophy (FSHD) COMPLETED
Blood Pressure Effects on Cognition and Brain Blood Flow in PD Parkinson Non applicable NCT05400174 Blood Pressure Effects on Cognition and Brain Blood Flow in PD RECRUITING
BI 3000202 Lupus Phase 2 NCT07409181 A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE) RECRUITING